Patient Outcomes | Dexcom Provider

Audience

Healthcare Providers
Patients

Utility

Dexcom Clarity Login
United States
- Deutschland
- 日本

Buttons Mobile

Rep & Samples

Main

Products
- G7 15 Day
  
  Overview
  
  Why CGM
  
  Overview
  
  Why CGM
- G7
  
  Overview
  
  Why CGM
  
  Overview
  
  Why CGM
- Stelo
  
  Overview
  
  Overview
- G Series Ecosystem
  
  Connected Partners
  
  Dexcom Follow App
  
  Connected Partners
  
  Dexcom Follow App
- Clarity
  
  Clarity
  
  Clarity
G7 15 Day for adult patients
Type 1, type 2, or gestational diabetes whether they use insulin or not
Requires a prescription
MEET G7 15 DAY
- G7 15 Day
  - Overview
  - Why CGM
  - Overview
  - Why CGM
- G7
  - Overview
  - Why CGM
  - Overview
  - Why CGM
- Stelo
  - Overview
  - Overview
- G Series Ecosystem
  - Connected Partners
  - Dexcom Follow App
  - Connected Partners
  - Dexcom Follow App
- Clarity
  - Clarity
  - Clarity
Patient Outcomes
- Intensively Treated
  
  Type 1 Diabetes
  
  Type 2 Diabetes on Insulin
  
  Diabetes in Pregnancy
  
  Type 1 Diabetes
  
  Type 2 Diabetes on Insulin
  
  Diabetes in Pregnancy
- Non-intensively Treated
  
  Type 2 Diabetes Not on Insulin
  
  Type 2 Diabetes Not on Insulin
- Emerging Data
  
  Overview
  
  Overview
- Intensively Treated
- Non-intensively Treated
  - Type 2 Diabetes Not on Insulin
  - Type 2 Diabetes Not on Insulin
- Emerging Data
  - Overview
  - Overview
Coverage & Prescribing
- Coverage & Prescribing
  
  Coverage Tools
  
  Formulary Lookup
  
  Coverage Evaluator
  
  How to Prescribe
  
  Coverage Tools
  
  Formulary Lookup
  
  Coverage Evaluator
  
  How to Prescribe
- Coverage & Prescribing
Tools & Resources
- In-Office
  
  In-Office Resources
  
  In-Office Resources
- Health systems
  
  EHR Integration
  
  Hospital Discharge Program
  
  EHR Integration
  
  Hospital Discharge Program
- Pharmacy
  
  Pharmacy Resources
  
  Pharmacy Resources
- Clinical Resources
  
  Clinical Education Resources
  
  Clinical Education Resources
- Events
  
  Events & Webinars
  
  Events & Webinars
Coverage & Affordability
More patients pay $0 for Dexcom G7 15 Day CGM compared to Libre*
LEARN MORE
Ready to request samples?
Free samples available for quick and easy start.
REQUEST NOW
In-Office Resources
Download resources to help your patients start and stay on Dexcom CGM.
SEE RESOURCES
- In-Office
  - In-Office Resources
  - In-Office Resources
- Health systems
  - EHR Integration
  - Hospital Discharge Program
  - EHR Integration
  - Hospital Discharge Program
- Pharmacy
  - Pharmacy Resources
  - Pharmacy Resources
- Clinical Resources
  - Clinical Education Resources
  - Clinical Education Resources
- Events
  - Events & Webinars
  - Events & Webinars
Support
- Support
  
  Patient Support Program
  
  Patient Support Program
- FAQs
  
  Frequently Asked Questions
  
  Frequently Asked Questions
- Contact Us
  
  Contact Us
  
  Contact Us
- Support
  - Patient Support Program
  - Patient Support Program
- FAQs
  - Frequently Asked Questions
  - Frequently Asked Questions
- Contact Us
  - Contact Us
  - Contact Us

Buttons Desktop

Rep & Samples

Main

Products
- G7 15 Day
  - Overview
  - Why CGM
- G7
  - Overview
  - Why CGM
- Stelo
  - Overview
- G Series Ecosystem
  - Connected Partners
  - Dexcom Follow App
- Clarity
  - Clarity
Patient Outcomes
Coverage & Prescribing
- Coverage & Prescribing
Tools & Resources
Support

Audience

Healthcare Providers
Patients

Utility

Dexcom Clarity Login
United States
- Deutschland
- 日本

Search

Breadcrumb

Home
Patient Outcomes

See the data—Dexcom G7 CGM improved outcomes for pediatric patients with diabetes

see patient outcomes

Dexcom healthcare provider

Request a representative visit or G7 15 Day or G7 samples

Dexcom, headquartered in San Diego, is dedicated to helping people better manage their diabetes by developing and marketing continuous glucose monitoring (CGM) products and tools for adult and pediatric patients.

Footer

Products
- G7 15 Day
- G7
- Stelo
- Clarity
coverage & affordability
Tools & Resources
Support

BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries.

MAT-11233

Support

Terms of Use
Privacy Policy
Safety Information
SITEMAP

Copyright © 2026 Dexcom